With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. b) Standalone Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 1:00 p.m. We request you to kindly take the same on record.

With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. b) Standalone Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 1:00 p.m. We request you to kindly take the same on record.

The exchange is hereby informed that the Company will hold Post Results Conference Call on 19th January, 2021 as per the enclosed details. We request you to kindly take the same on record.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspaper on 8th January, 2021 in Economic Times English Edition, Indian Express English Edition and Financial Express Gujarati Edition. We request you to kindly take the same on record.

Alembic Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here

ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2021 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Tuesday, 19th January, 2021, inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended 31st December, 2020. Pursuant to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st January, 2021, will re-open 48 hours after the declaration of the financial results. We request you to kindly take the same on record.

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- Charandeep Singh SalujaDesignation :- Company Secretary and Compliance Officer

With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2020, received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. We request you to kindly take the same on record.

With reference to the captioned matter, this is to inform the exchange that in terms of the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will remain closed from 1st January, 2021 till 48 hours after the declaration of the unaudited financial results for the quarter and nine months period ended 31st December, 2020. The date of the Board Meeting for considering the unaudited financial results for the quarter and nine months period ended 31st December, 2020 will be intimated in due course. We request you to kindly take the same on record.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificate(s) published by the Company on behalf of the registered shareholder(s) in English language newspaper - Business Standard on 25th December, 2020. We request you to kindly take the same on record.